Plain-English translation of NCT07598669 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Primary Biliary Cholangitis research guide →This is a long-term observation study of people with primary biliary cholangitis, a rare disease where the immune system damages the bile ducts in the liver. Rather than testing a new medication, researchers are collecting detailed information about patients' symptoms, test results, and how their disease develops over time. This information will help doctors better understand the disease and improve care for future patients.
Primary biliary cholangitis is uncommon, and doctors don't have enough detailed information about how different patients experience it and respond to current treatments. By carefully tracking many patients over time, researchers hope to identify patterns that could improve diagnosis and care.
You likely qualify if…
You likely don't qualify if…
You would visit a participating liver clinic in Austria every 3 to 6 months (or more often if medically needed) for routine care and check-ups. During these visits, your doctors will record information about your symptoms, run blood tests, and monitor your liver health using standard imaging and measurements. If you consent, leftover blood samples or tissue from routine biopsies will be stored for future research. You will continue to receive your regular treatment as usual — no experimental drugs or procedures are involved.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
Austria